292 related articles for article (PubMed ID: 32907497)
1. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
[TBL] [Abstract][Full Text] [Related]
2. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
[TBL] [Abstract][Full Text] [Related]
3. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD
Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846
[TBL] [Abstract][Full Text] [Related]
4. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
[TBL] [Abstract][Full Text] [Related]
5. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
[TBL] [Abstract][Full Text] [Related]
6. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors.
Gomez J; Holmes N; Hansen A; Adhikarla V; Gutova M; Rockne RC; Cho H
Math Biosci Eng; 2022 Jan; 19(3):2592-2615. PubMed ID: 35240798
[TBL] [Abstract][Full Text] [Related]
8. Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.
Barish ME; Herrmann K; Tang Y; Argalian Herculian S; Metz M; Aramburo S; Tirughana R; Gutova M; Annala A; Moats RA; Goldstein L; Rockne RC; Gutierrez J; Brown CE; Ghoda L; Aboody KS
Stem Cells Transl Med; 2017 Jun; 6(6):1522-1532. PubMed ID: 28481046
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
[TBL] [Abstract][Full Text] [Related]
10. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.
López-Ornelas A; Vergara P; Segovia J
Cytotherapy; 2014 Jul; 16(7):1011-23. PubMed ID: 24529556
[TBL] [Abstract][Full Text] [Related]
12. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
Buckley A; Hagler SB; Lettry V; Bagó JR; Maingi SM; Khagi S; Ewend MG; Miller CR; Hingtgen SD
Mol Ther; 2020 Jul; 28(7):1614-1627. PubMed ID: 32402245
[TBL] [Abstract][Full Text] [Related]
13. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
14. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
[TBL] [Abstract][Full Text] [Related]
15. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
Okolie O; Irvin DM; Bago JR; Sheets K; Satterlee A; Carey-Ewend AG; Lettry V; Dumitru R; Elton S; Ewend MG; Miller CR; Hingtgen SD
PLoS One; 2018; 13(7):e0198596. PubMed ID: 29990322
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
Kauer TM; Figueiredo JL; Hingtgen S; Shah K
Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
[TBL] [Abstract][Full Text] [Related]
17. Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.
Lorico A; Mercapide J; Solodushko V; Alexeyev M; Fodstad O; Rappa G
Cancer Gene Ther; 2008 Sep; 15(9):605-15. PubMed ID: 18421309
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma.
Gutova M; Flores L; Adhikarla V; Tsaturyan L; Tirughana R; Aramburo S; Metz M; Gonzaga J; Annala A; Synold TW; Portnow J; Rockne RC; Aboody KS
Front Oncol; 2019; 9():68. PubMed ID: 30838174
[TBL] [Abstract][Full Text] [Related]
19. Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
Bagó JR; Pegna GJ; Okolie O; Hingtgen SD
Biomaterials; 2016 Apr; 84():42-53. PubMed ID: 26803410
[TBL] [Abstract][Full Text] [Related]
20. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
Cheng SH; Yu D; Tsai HM; Morshed RA; Kanojia D; Lo LW; Leoni L; Govind Y; Zhang L; Aboody KS; Lesniak MS; Chen CT; Balyasnikova IV
J Nucl Med; 2016 Feb; 57(2):279-84. PubMed ID: 26564318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
